Browse > Article
http://dx.doi.org/10.9799/ksfan.2012.25.4.713

Anti-Metastatic Activity of Juniperus chinensis Extract by Galectin-3 Inhibition  

Lee, Keyong Ho (Chong Kun Dang Research Institute, CKD Pharmaceuticals Inc.)
Rhee, Ki-Hyeong (College of Industrial Sciences, Kongju National University)
Publication Information
The Korean Journal of Food And Nutrition / v.25, no.4, 2012 , pp. 713-718 More about this Journal
Abstract
The purpose of this study was to examine the anti-metastatic effect of Juniperus chinensis extract by inhibition of galectin-3 expression. For this study, we carried out the experiment of galectin-3 expression assay and in vivo metastasis mouse model bearing colon 26-M3.1 lung carcinoma, and also MMP-1, MMP-2 and MMP-9 inhibitory assays relating metastasis mechanism. J. chinensis extract significantly showed the inhibitory effect of basal expression and MNNG-induced expression of galectin-3 in colon 26-M3.1 lung carcinoma at the all tested doses (5, 50 and $500{\mu}g/m{\ell}$). In case of the inhibition of MMP-1, MMP-2 and MMP-9, the weak activity was showed at the doses of 50 and $500{\mu}g/m{\ell}$ and was not detected at the dose of $5{\mu}g/m{\ell}$. However, J. chinensis extract significantly showed the anti-metastatic activity on mouse mode bearing colon 26-M3.1 lung carcinoma. Therefore, this study strongly suggests that J. chinensis is a potent inhibitor of galectin-3 expression, and holds great promise for use in inhibiting metastasis induced by elevated expression of galectin-3.
Keywords
Juniperus chinensis; galectin-3; MMPs;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Ali AM, Mackeen MM, Intan-Safinar I, Hamid M, Lajis NH, el-Sharkawy SH, Murakoshi M. 1996. Antitumour-promoting and antitumour activities of the crude extract from the leaves of Juniperus chinensis. J Ethnopharmacol 53:165-169   DOI   ScienceOn
2 Azzam HS, Arand G, Lippman ME, Thompson EW. 1993. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J Natl Cancer Inst 85:1758-1764   DOI   ScienceOn
3 Bae KH. 2000. Medicinal Plants of Korea, Kyohaksa, Seoul. pp. 39
4 Bae YS, Si CL, Kim JK, Darchesy JJ. 2005. Extractive of Juniper needle. J Kor For En 24:24-30   과학기술학회마을
5 Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A. 1998. Metastasis of human colon cancer is altered by modifying expression of the beta-galactosidebinding protein galectin 3. Gastroenterology 115:287-296   DOI   ScienceOn
6 Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, Hattori K, Tomiyama Y, Raz A, Kubo T. 2000. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6:4635-4640
7 Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. 2002. Galectin- 3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 40:80-87   DOI   ScienceOn
8 Dumic J, Dabelic S, Floel M. 2002. Curcumin: A potent inhibitor of galectin-3 expression. Food Technol Biotechnol 40:281-287
9 Gabius HJ. 1997. Animal lectins. Eur J Biochem 243:543-576   DOI   ScienceOn
10 Honjo Y, Nangia-Makker P, Inohara H, Raz A. 2001. Downregulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 7:661-668
11 Hughes RC. 1999. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1473: 172-185   DOI   ScienceOn
12 Jin MH, Park SG, Hwang YL, Lee MH, Jeong NJ, Roh SS, Lee Y, Kim CD, Lee JH. 2012. Cedrol enhances extracellular matrix production in dermal fibroblasts in a MAPK-dependent manner. Ann Dermatol 24:16-21   DOI
13 Juliao SF, Rand N, Schwartz HS. 2002. Galectin-3: A biologic marker and diagnostic aid for chordoma. Clin Orthop Relat Res 397:70-75   DOI
14 Kagawa D, Jokura H, Ochiai R, Tokimitsu I, Tsubone H. 2003. The sedative effects and mechanism of action of cedrol inhalation with behavioral pharmacological evaluation. Planta Med 69:637-641   DOI   ScienceOn
15 Manter DK, Kelsey RG, Karchesy JJ. 2007. Antimicrobial activity of extractable conifer heartwood compounds toward Phytophthora ramorum. J Chem Ecol 33:2133-2147   DOI
16 Kim SJ, Jung JY, Kim HW, Park T. 2008. Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats. Biol Pharm Bull 31:1415-1421   DOI   ScienceOn
17 Kim SJ, Shin JY, Lee KD, Bae YK, Choi IJ, Park SH, Chun KH. 2011. Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1). PLoS One 6:e25103   DOI   ScienceOn
18 Kim YW, Ko YT, Kim NK, Chung HC, Min BS, Lee KY, Park JP, Kim H. 2010. A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: The significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis. Scand J Gastroenterol 45:217-225   DOI   ScienceOn
19 Lim JP, Song YC, Kim JW, Ku CH, Eun JS, Leem KH, Kim DK. 2002. Free radical scavengers from the heartwood of Juniperus chinensis. Arch Pharm Res 25:449-452   과학기술학회마을   DOI   ScienceOn
20 Loizzo MR, Tundis R, Menichini F, Saab AM, Statti GA, Menichini F. 2008. Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells. Cell Prolif 41:1002-1012   DOI   ScienceOn
21 Moon SH, Park KY. 2000. Antioxidative effect of persimmon leaves. Korean J Food & Nutr 13:53-58   과학기술학회마을
22 Song YK, Billiar TR, Lee YJ. 2002. Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. Am J Pathol 160:1069-1075   DOI   ScienceOn
23 Nakamura M, Inufusa H, Adachi T, Aga M, Kurimoto M, Nakatani Y, Wakano T, Nakajima A, Hida JI, Miyake M, Shindo K, Yasutomi M. 1999. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol 15:143-148
24 O'Brien S, Kay NE. 2011. Maintenance therapy for B-chronic lymphocytic leukemia. Clin Adv Hematol Oncol 9:22-31
25 Plzak J, Smetana K Jr, Hrdlickova E, Kodet R, Holikova Z, Liu FT, Dvorankova B, Kaltner H, Betka J, Gabius HJ. 2001. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation. Int J Oncol 19:59-64
26 Woo HJ, Shaw LM, Messier JM, Mercurio AM. 1990. The major non-integrin laminin binding protein of macrophage is identical to carbohydrate-binding protein 35 (Mac-2). J Biol Chem 265:7079-7099
27 Suh SJ, Kim JR, Jin UH, Choi HS, Chang YC, Lee YC, Kim SH, Lee IS, Moon TC, Chang HW, Kim CH. 2009. Deoxypodophyllotoxin, flavolignan, from Anthriscus sylvestris Hoffm inhibits migration and MMP-9 via MAPK pathways in TNF-alpha-induced HASMC. Vascul Pharmacol 51:13-20   DOI   ScienceOn
28 Sung JY, Yoon TJ, Yu KW, Lee KH, Lee H. 2006. Enhancement of immunological activities in mice by oral administration of pectic polysaccharides from Eleutherococcus senticosus. Food Sci Biotechnol 15:117-121   과학기술학회마을
29 Tester AM, Ruangpanit N, Anderson RL, Thompson EW. 2000. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits. Clin Exp Metastasis 18:553-560   DOI
30 Woo HJ, Lotz MM, Jung JU, Mercurio AM. 1991. Carbohydratebinding protein 35 (Mac-2), a laminin-binding lectin, forms functional dimers using cysteine. J Biol Chem 266:18419- 18422
31 Woo JY, Paek NS, Kim YM. 2005. Studies on antioxidative effect and lactic acid bacteria growth of persimmon leaf extracts. Korean J Food & Nutr 18:28-38   과학기술학회마을
32 Yang RY, Hsu DK, Liu FT. 1996. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93:6737-6742   DOI   ScienceOn
33 Yook CS. 1981. Medical Plants of Korea. Jinmyeong, Seoul. pp. 17
34 Yoshii T, Inohara H, Takenaka Y, Honjo Y, Akahani S, Nomura T, Raz A, Kubo T. 2001. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Int J Oncol 18:787-792